Drug Manufacturing is the method through which Pharmaceutical Companies create medications on an industrial scale. The processes used to make drugs may be divided into a number of unit operations. The procedure may include milling, granulation, coating, and tablet pressing. The pharmaceutical sector is a crucial part of the global health care infrastructure. It is made up of businesses that are both public and private that find, develop, produce, and sell medications. The creation of medications that either prevent or treat illnesses and disorders is the mainstay of the Pharmaceutical Business. The creation and spread of novel medications with greater therapeutic effectiveness and fewer side effects is accelerating because to contemporary scientific and technical advancements. Increased potency and specificity of medications is a goal shared by medicinal chemists, molecular biologists, and pharmacists. The method through which pharmaceutical corporations create pharmaceuticals on an industrial scale is known as drug manufacturing. A number of unit activities make up the processes used to make drugs. Possible steps in the process include milling, granulating, coating, and tablet pressing.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia